INTRODUCTION
============

Human reproductive failure is as old as mankind. This public health problem involves all regions of the world and its prevalence worldwide varies from 10-15%^[@R1]^; 10-32% in Africa^[@R2]^ and 31.5% in Nigeria^[@R3]^. The various categories of human reproductive failure include: infertility, recurrent pregnancy loss (spontaneous miscarriages or abortions and preterm birth) and ectopic pregnancy. Causes include environmental and lifestyle factors, congenital malformations, endocrine disorders, immunologic abnormalities and sequelae of genital tract infections^[@R4]^,^[@R5]^.

The association of infertility with genital tract infections (GTIs) or sexually transmitted infections has been demonstrated. GTIs associated with human reproductive failure include: Treponema pallidum, Neisseria gonorrheae, Chlamydia trachomatis, Trichomonas vaginalis and Schistosoma haematobium infections among others. The spread of gonococcal and Chlamydial infection to upper female genital tract may cause pelvic inflammatory disease with severe tubal scarring leading to tubal infertility^[@R6]^. Genital tract infections evoke both cellular and humoral immune response leading to activation of polymorphonuclear leucocytes, macrophages and the release of cytokines. These immunologic factors produced in response to GTIs influence various aspects of reproduction including follicle development, ovulation, luteinisation, oocyte quality, fertilization, implantation, foetal development and pregnancy immunotolerance^[@R7]^-^[@R9]^.

Abnormal immunologic profile which in part is characterized by autoantibody abnormalities have been described in infertile women^[@R10]^. GTIs induce increased production of reactive oxygen species and nitric oxide leading to oxidative stress which has been implicated in the pathophysiology of tubal and peritoneal factor infertility, endometriosis, preeclampsia, hydatidiform mole, free radical-induced birth defects and abortions^[@R11]^-^[@R16]^. Their pathological effects are exerted by various mechanisms including lipid peroxidation, peroxidative DNA damage, mitochondrial alterations and apoptosis^[@R17]^. The complex interplay between GTI and its induction of oxidative stress and pathologic immune response both systemic and locally and the deleterious effects of these responses on the male and female genital tract which include tissue damage, tubal scarring, pelvic inflammatory disease, chronic salpingitis, endometritis and distal tubal obstruction have been implicated as pathologic mechanisms of infertility.

Excessive weight and central distribution of body fat have been related to an increased risk of normogonadotrophic anovulation^[@R18]^. High body mass index (BMI) has been implicated in development of insulin resistance and hyperinsulinaemia. Elevated insulin levels have been reported to inhibit the conversion of testosterone to oestrogen. Lower levels of oestrogen will lead to anovulation and infertility^[@R19]^. Obesity appears to have a major impact on reproductive performance and can compromise it in a variety of ways; including menstrual disorders and anovulation. Weight reduction in obese patients reduces hyperandrogenism and hyperinsulinaemia; both of which factors influence the ovarian response to follicular stimulating hormone. Weight loss can re-establish ovulation in obese anovulatory patients or improve their response to ovulation induction. Clark *et al*. ^[@R20]^ in 1995 found that weight loss re-established ovulation in obese anovulatory patients or improved their response to ovulation induction: in a series of 67 anovulatory women, 90% resumed ovulation after weight loss and 78% conceived. The same study group confirmed these findings in a larger series^[@R21]^. Similar results were obtained in preliminary observations by Crosignani *et al*., 1999 ^[@R22]^ and 2002 ^[@R23]^. In another series, among the 27 out of 33 patients with irregular menstrual cycles who lost weight, 18 re-established regular cycles ^[@R18]^. A total of 60% had ovulatory levels of plasma progesterone after weight loss. Neither menstrual cycle improvement, nor ovulatory values of progesterone nor pregnancies occurred in the eight patients who did not lose weight. Therefore, it is presumed that obesity may be responsible for the relative ovarian insensitivity to infertility treatment^[@R18]^

This study aimed to investigate the association of Chlamydial infection, obesity and oxidative response with tubal infertility in Nigerian women.

MATERIALS AND METHODS
=====================

Study design
------------

This case control study was conducted in the University College Hospital (UCH), Ibadan, Nigeria. It served as a pilot for an on-going larger work studying the association of oxidative stress and pathologic response to stress with infertility. The study population comprised of female patients of reproductive age attending the Infertility Clinic and a control group of age-matched fertile women who were new clients at the Family Planning Clinic. The study protocol was approved by UI/UCH Ethical Committee (Ref UI/ EC/08/0083).

Hypothesis
----------

The hypothesis was that tubal infertility is not associated with oxidative stress and obesity. The outcome measures were the anthropometric and oxidative stress parameters of the subjects.

Selection of Subjects
---------------------

Forty consenting women with infertility of at least one year's duration (with tubal blockage identified by hysterosalpingography) were recruited from the infertility clinic, while 32 controls were recruited from the family planning clinic. The controls were women without previous infertility who had childbirth within the last two years, and who had not been on any form of contraception prior to recruitment. Exclusion criteria included women that were undergoing any form of contraceptive therapy, previous history of uterine surgery, malignancy, long term medication, chronic organ or systemic illness and those who did not give consent.

Forty consenting women with infertility of at least one year's duration (with tubal blockage identified by hysterosalpingography) were recruited from the infertility clinic, while 32 controls were recruited from the family planning clinic. The controls were women without previous infertility who had childbirth within the last two years, and who had not been on any form of contraception prior to recruitment. Exclusion criteria included women that were undergoing any form of contraceptive therapy, previous history of uterine surgery, malignancy, long term medication, chronic organ or systemic illness and those who did not give consent.

Anthropometric indices (height, weight, waist and hip circumferences) were taken to calculate the body mass index and waist-hip ratio (WHR) respectively.

Sample Collection
-----------------

Ten millilitres of venous blood samples were collected aseptically from each subject on days 3-5 and 21-23 of a 28-30 day menstrual cycle, respectively. The samples were dispensed into universal containers. After clot retraction, the samples were centrifuged at 3000 rev/s for ten minutes after which serum was extracted and stored in small aliquots at -20oC. High vaginal swabs (HVS) and endocervical swabs (ECS) were also taken from all subjects of study using sterile swab sticks for detection of common sexually-transmitted infections.

Laboratory Methods
------------------

Endocrinological analysis: follicular stimulating hormone (FSH), luteinizing hormone (LH), progesterone (P4), estradiol (E2) and prolactin (PRL) were measured with enzyme immunoassay method (EIA) from Immunometrics Ltd., London, UK.

Antioxidant profile: total antioxidant potential (TAP) was estimated using the ferric reducing antioxidant power (FRAP) method of Benzie and Strain^[@R24]^. Total plasma peroxides (TPP), as a biomarker of Oxidative Stress (OS), were estimated using the modified FOX 2 method of Harma *et al*.^[@R25]^. Oxidative stress index (OSI) was calculated as a ratio of TPP/TAP.

Microbiological Analysis: screening for Trichomonas vaginalis was by microscopy while Neisseria gonorrheae was by gram staining, followed by culture if necessary. Immunologic analysis: endocervical swabs were tested for Chlamydia trachomatis antigen with a rapid screening test (DiaSpot™, Bresta Perkasa, Indonesia). Serum was screened for Treponema pallidum antibodies (IgG & IgM) by immunochromatographic method with Exact® syphilis diagnostic device, USA; and Chlamydia trachomatis antibodies (CT IgG) with ImmunoComb®, Orgenics Ltd., Yavne, Israel.

Statistical Analysis
--------------------

Data was analyzed using the statistical package of social science (SPSS) software 15.0 version. For quantitative variables, paired student's t-test was used to test for mean differences. Pearson's correlation analysis was employed to determine associations between variables. For non-quantitative variables, χ -square analysis was used for determination of associations between variables. Significant p was \<0.05.

RESULTS
=======

The screening tests for the afore-mentioned were all negative, suggesting that none of the patients had current genital tract infection. Chlamydial antibodies were further tested for; to identify women with previous infection which may have led to the tubal damage. Table [1](#T1){ref-type="table"} shows the comparison of Chlamydia $$\begin{matrix}
{\text{OR} = 4.33,\ 95\%\ CI\left( {{0.078} - 0.681} \right)} \\
{2 = 7.847,\ df = 1,\operatorname{P=}0.005} \\
\end{matrix}$$ $$\begin{matrix}
{\text{CT\ IgG}\operatorname{=~}\text{Chlamydia\ trachomatis\ immunoglobulin\ G}} \\
\text{+ve\ =\ Positive} \\
{- \text{ve\ =\ Negative}} \\
\end{matrix}$$ trachomatis IgG (CT IgG) antibody positivity in fertile and infertile women. The fertile group of the study population were significantly less likely to have Chlamydia trachomatis antibodies than the infertile group \[OR=4.33; 95%CI (0.078-0.681)\].

Table [2](#T2){ref-type="table"} shows the comparison of anthropometric data, hormone profiles and antioxidant parameters among fertile and infertile women; luteinizing hormone was significantly higher in the infertile group.

The correlation of anthropometric indices with oxidative stress and hormonal parameters showed that BMI had a significant positive correlation with TPP (p\<0.001) and OSI (p-0.001) in the infertile group but not in controls. In infertile women, waist circumference (p-0.006) and hip circumference (p\<0.001), respectively, correlated negatively with oestrogen.

DISCUSSION
==========

The total antioxidant potential (TAP), total plasma peroxides (TPP) and therefore, oxidative stress index (OSI) were not significantly different between infertile women and their fertile controls. This finding is in agreement with other authors, who reported no significant differences in TAP in infertile and fertile controls^[@R26]^,^[@R27]^. Total plasma peroxides were positively associated with BMI; this indicated that increasing BMI may be a risk factor for increased oxidative stress and the associated deleterious effects on the general body system. Oxidative stress has been implicated in the pathogenesis of more than 100 disease conditions including infertility^[@R16]^. The place of obesity in anovulatory infertility has been discussed---however, the subjects of the current study were ovulating, as observed by their mid-luteal progesterone assays. This finding suggests that BMI may increase oxidative stress and its influence on infertility in the absence of anovulation.

The negative correlation observed between oestradiol and waist and hip circumferences imply that obesity in women may lead to a hormonal imbalance that may reduce their fertility. It has been reported that ovulating subfertile women with a BMI over 29 kg/m2 have lower pregnancy rates compared with those with normal weight^[@R28]^. Our study also points to this fact as indicated by the increased oxidative stress.

We did not expect the fertility hormone profile to be significantly different between infertile and fertile women in this study; the profile was studied to ascertain that the cases did not have anovulatory infertility, which could be a confounder. The only isolated significant hormone was luteinizing hormone. The current study cannot fully explain the association; however, the midluteal progesterone suggested these women were actually ovulating---therefore, the elevated LH may be of little consequence. The study design did not allow for testing mid-luteal progesterone in the controls. We required these fertile controls to be contraceptive- and hormone-naïve, so they were recruited at their first visit to family-planning clinic. A mid-luteal progesterone assay would have required a follow-up visit, but by this time, they would have been commenced on a contraceptive method, so would not be suitable for inclusion any longer. The relatively high values of prolactin in the fertile women were probably because most of them were still nursing their infants at the time of recruitment. The prevalence of Chlamydia antibody positivity was found to be significantly higher in infertile women compared to their fertile controls. This finding is in agreement with the findings of other workers^[@R3]^,^[@R29]^-^[@R34]^. Chlamydial infection evokes pathologic immune response and generation of reactive oxygen species which results in inflammatory response, apoptosis, tissue damage, scarring, fibrosis, hydrosalpinx, tubal occlusion leading to tubal infertility^[@R16]^.

The findings of this study may be limited by the small sample size; the association of obesity with tubal infertility may be validated in the larger study to follow. The study will include evaluation of cellular as well as humoral pathologic response found associated with tubal infertility, and will hopefully shed more light on the aetiopathogenesis of infertility.

CONCLUSION
==========

Previous Chlamydial infection is significantly associated with tubal factor infertility. Obesity seems to reduce fertility potential in women with tubal factor infertility as well as increase oxidative stress. Larger studies are required to explore this.

###### 

Comparison of Chlamydia trachomatis IgG (CTIgG) antibody positivity in Fertile and Infertile Women

               Infertile(n=40)   Fertile(n=32)   Total
  ------------ ----------------- --------------- -------
  *CTIgG+ve*                                     
  Subjects     20                6               26
  \%           50.0              18.3            
  *CTIgG-ve*                                     
  Subjects     20                26              46
  \%           50.0              81.7            
               40                32              72

###### 

Comparison of anthropometric data, hormone profiles and antioxidant parameters in Fertile and Infertile Women

                                                 Infertile     Fertile               
  ---------------------------------------------- ------------- ------------ -------- -------
  Age (yrs)                                      32.3±4.0      33.5±4.8     -1.185   0.240
  Weight (kg)                                    69.2±11.4     66.1±14.4    1.019    0.312
  Height (m)                                     1.6 ± 0.1     1.6 ± 0.1    0.423    0.673
  BMI (kg/m^2^)                                  27.1±0.4      26.1±5.1     0.879    0.382
  WC (cm)                                        84.9±8.3      84.4±12.4    0.179    0.858
  HC (cm)                                        103.7±9.6     103.0±12.4   0.272    0.786
  WHR                                            0.82±0.0      0.82±0.1     -0.027   0.979
  TAP (µmol TE/L)                                767.9±146.8   748.9±90.2   0.643    0.522
  (µmol H~2~O~2~/L)                              6.3±7.8       4.4±1.4      1.337    0.185
  OSI                                            0.9±0.9       0.6±0.2      1.569    0.121
  FSH (IU/L)                                     13.4±11.8     10.1±4.7     1.462    0.148
  LH (IU/L)                                      16.1±21.2     5.7±3.9      2.712    0.008
  Prolactin (IU/L)                               452.2±486.2   611±874.9    -0.976   0.332
  P4 (pmol/L)[\*](#T2FN1){ref-type="table-fn"}   22.6±19.8     \-           3.264    \-
  E2 (pmol/L)                                    0.85±1.87     0.51±0.41    1.000    0.321

see text for explanation^1^

BMI- body mass index, WC-waist circumference, HC-hip circumference, WHR- waist-hip ratio, TAP- total antioxidant potential, TPPtotal plasma peroxides, OSI- oxidative stress index, FSH-follicular-stimulating hormone, LH-luteinizing hormone, P4-progesterone, E2- oestrogen
